Agenus Inc., an immune-oncology company, has appointed José Iglesias, M.D. as Chief Medical Affairs Officer.

Halozyme Therapeutics has acquired Elektrofi, a biopharmaceutical company with a proprietary ultra-high concentration ...

Debiopharm has launched the IDEAL Japan initiative, a new program designed to provide financial support to Japanese academic ...

Thermo Fisher Scientific Inc. has opened its East Coast flagship Advanced Therapies Collaboration Center (ATxCC) in ...

Celltrion announced that the European Commission (EC) has granted marketing authorization for Remsima IV (intravenous) liquid ...

BioDuro has launched a new Business Unit dedicated to advancing peptide drug discovery and development for its global biopharma partners.

On September 18th and 19th, Contract Pharma hosted its 24th Annual Contracting & Outsourcing Conference & Tabletop Exhibition ...

On September 18th and 19th, Contract Pharma hosted its 24th Annual Contracting & Outsourcing Conference & Tabletop Exhibition ...

On September 18th and 19th, Contract Pharma hosted its 24th Annual Contracting & Outsourcing Conference & Tabletop Exhibition ...

On September 18th and 19th, Contract Pharma hosted its 24th Annual Contracting & Outsourcing Conference & Tabletop Exhibition ...

Tyruko will be commercialized in the U.S. by its collaboration partner Sandoz, under an exclusive global license agreement. Polpharma Biologics S.A., operating under the Rezon Bio brand and ...

Merus N.V. and Halozyme Therapeutics Inc. have entered into a global non-exclusive collaboration and license agreement.